| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | President and CEO | May 17, 2023 | Buy | $3.70 | 5,000 | 18,525 | 266,829 | May 18, 2023, 02:13 PM | |
| LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | President and CEO | Sep 16, 2022 | Buy | $3.15 | 31,746 | 100,000 | 56,829 | Sep 19, 2022, 07:00 AM | |
| TLGT | Teligent, Inc. | BEN-MAIMON CAROLE | Director | May 30, 2019 | Buy | $0.59 | 10,000 | 5,885 | 16,000 | May 31, 2019, 10:39 AM | |
| TLGT | Teligent, Inc. | BEN-MAIMON CAROLE | Director | Nov 13, 2017 | Buy | $3.48 | 5,000 | 17,409 | 6,000 | Nov 13, 2017, 05:01 PM | |
| IPXL | IMPAX LABORATORIES INC | BEN-MAIMON CAROLE | President, Global Pharm. | Oct 25, 2013 | Option Exercise | $18.93 | 6,734 | 127,475 | 62,914 | Oct 28, 2013, 06:48 PM | |
| IPXL | IMPAX LABORATORIES INC | BEN-MAIMON CAROLE | President, Global Pharm. | Oct 10, 2013 | Option Exercise | $18.93 | 5,282 | 99,988 | 56,180 | Oct 15, 2013, 12:18 PM | |
| IPXL | IMPAX LABORATORIES INC | BEN-MAIMON CAROLE | President, Global Pharm. | May 23, 2013 | Option Exercise | $18.60 | 399 | 7,421 | 50,898 | May 28, 2013, 08:10 PM | |
| IPXL | IMPAX LABORATORIES INC | BEN-MAIMON CAROLE | President, Global Pharm. | Oct 28, 2012 | Option Exercise | $24.34 | 1,836 | 44,688 | 26,497 | Oct 29, 2012, 07:35 PM |
Menu